CWF19L1

Across TCGA pan-cancer cohorts, CWF19L1 Mutation is linked to patient survival in 7 of 34 cancer types, making it a survival-associated CWF19L1 data layer compared with 21 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CWF19L1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated CWF19L1 expression acts as an unfavorable survival marker.

LUAD, STAD, and KIRC are the cancer types where CWF19L1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.098	0.791	<.001	18	view →
STAD	OS	Median	II,III,IV	0.183	0.660	.009	12	view →
KIRC	OS	Median	All	0.125	0.881	<.001	12	view →
ESCA	DFS	Median	All	0.052	0.533	<.001	12	view →
SCLC	OS	Median	All	0.219	0.706	.011	6	view →
LIHC	OS	Median	All	0.255	0.773	.012	6	view →
BLCA	DFS	Median	IV	0.025	0.476	<.001	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

CWF19L1–LUAD (DFS)

Open the LUAD breakdown →